Click here to close now.

Welcome!

News Feed Item

IntelliCell BioSciences Announces It Will File an IND for Osteoarthritis of the Knee in Conjunction With the Andrews's Research and Educational Foundation

NEW YORK, NY -- (Marketwired) -- 03/17/14 -- IntelliCell Biosciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it has signed consulting agreements with Dr Adam Anz and Dr Josh Hackel of the Andrews's Research and Education Foundation (AREF) in Gulf Breeze, Florida. Intellicell will be filing an IND for the treatment of osteoarthritis of knee lead by Dr. James Andrews and conducted by Drs. Anz and Hackel for its Stromal Vascular Fraction Cells (SVFC).

IntelliCell's Chief Executive Officer, Dr. Steven Victor, remarked, "I am excited that the company will be filing its first IND for osteoarthritis of the knee and has the honor to be working with Dr. Andrews, Dr. Anz and Dr. Hackel. They are the some of the most prominent sports medicine physicians in the company. Dr. Anz and Dr. Hackel bring their vast knowledge and experience in stem cells to this project. With this distinguished group of doctors on board we will be able to advance the research and science of the SVF cellular product in the fields of orthopedic and sports medicine."

As said by Dr. Adam Anz, "Dr. Victor, through Intellicell Biosciences, has been a pioneer in the clinical application of stem cell therapy in the United States. His interactions with the FDA have helped us understand the current regulatory status, and he has a practice, which recently has passed their scrutiny. At the Andrews Research and Education Institute, we look forward to collaborating with him and to applying his technology in a compliant fashion. Working together we will produce evidence about the value of stem cell therapy for the treatment of joint injuries and degeneration, which will help us treat our patients better."

According to Dr. Josh Hackel, "We have recognized IntelliCell BioSciences as a forward thinking company and we are excited to continue FDA compliant research in this area as it relates to sports medicine and the treatment of our patients. It will be research like this at the Andrews Research and Education Institute in collaboration with IntelliCell BioSciences that will further our understanding and improve our management of sports medicine injuries."

About IntelliCell Biosciences
IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels in the adult adipose tissue. IntelliCell Biosciences has developed its own patented technology and protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. IntelliCell will also be seeking to develop technology-licensing agreements with technology developers, universities, and international business entities.

About Dr. James Andrews
Dr. James Andrews is internationally known and recognized for his scientific and clinical research contributions in knee, shoulder and elbow injuries, as well as his skill as an orthopedic surgeon. Dr. Andrews is a founding partner and medical director for the Andrews Institute in Gulf Breeze, Florida. In addition, he is a founding member of the American Sports Medicine Institute (ASMI).

Dr. Andrews has been the mentor for more than 250 orthopedic/sports medicine fellows and more than 45 primary care sports medicine fellows. Involved in education and research in sports medicine and orthopedic surgery, he has made major presentations on every continent, and has authored numerous scientific articles and books.

About Dr. Adam Anz
Adam Williams Anz, M.D., is a fellowship trained orthopedic surgeon who specializes in sports related injuries, specifically focusing on complex knee surgery, hip arthroscopy, and innovative stem cell treatments. He has many peer-reviewed publications and presentations with a special interest in cartilage regeneration. His main goal is to keep patients of all ages as active as possible in the least invasive way possible.

He completed his orthopedic surgery residency training at Wake Forest University in Winston-Salem, North Carolina where he worked extensively with the Wake Forest Demon Deacons Football team. After residency, he completed a sports fellowship at the world-renowned Steadman Clinic in Vail, Colorado where he learned complex knee surgery from the famed Drs. Steadman and Laprade and hip arthroscopy from Dr. Philippon.

Dr. Anz has numerous orthopedic journal publications and a strong interest in research with projects including the use of CT 3-D reconstruction for subtle hip deformities and a biomechanical project involving MLB pitchers with elbow injury. Dr. Anz's strongest research interest is in cartilage regeneration. During residency he spent 3 weeks in Malaysia with Dr. Khay Yong Saw, an orthopedic surgeon who has pioneered a method to regenerate cartilage using a patient's own stem cells. He returned to Malaysia after his time at the Steadman Clinic for a stem cell fellowship and to work on preparing an application to the FDA in order to apply this cutting edge stem cell technology within the United States.

About Dr. Josh Hackel
Dr. Joshua Hackel, a sports medicine physician, specializes in the prevention, diagnosis, and conservative management of musculoskeletal injuries utilizing the latest medical techniques for anyone who is injured on the job or at home, a weekend warrior, professional, high school or recreational athlete.

Following his residency in 2003 in Family Practice at Columbus Regional Medical Center in Columbus, GA, Dr. Hackel accepted a fellowship at the American Sports Medicine Institute (ASMI) in Primary Care Sports Medicine under the direction of orthopedic surgeon Dr. James R. Andrews. Upon completion of the fellowship he was invited to become a member of the Andrews Orthopedic & Sports Medicine Center in Gulf Breeze, FL.

Dr. Hackel treats acute and chronic musculoskeletal injuries such as joint sprains, strains, knee, hip, elbow, foot, ankle and shoulder injuries, fractures and stress fractures, arthritis/degenerative joint disease, athletes with chronic or acute illnesses, and nutrition.

Dr. Hackel has a multitude of team physician experience in many different sport and recreational arenas. These include team physician for the University of West Florida, Troy University football, Birmingham Barons baseball (AA affiliate of the Chicago White Sox), Birmingham Power of the WNBA, Arena Football's Birmingham Steeldogs, Southeastern Conference (SEC) womenÂ's basketball tournament, Mercedes Olympic Marathon, and the Medical Director for the Pensacola Marathon.

Dr. Hackel practices in Gulf Breeze at the Andrews Orthopedic & Sports Medicine Center and serves as an Associate Clinical Professor of Medicine at Florida State School of Medicine.

Forward-Looking Statements
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "will reach," "will change," "will soon," "should," "could," "would," "may," "can" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
IntelliCell BioSciences, Inc.
Investor Relations
Anna Rhodes
Email Contact
(646) 576-8308

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
The time is ripe for high speed resilient software defined storage solutions with unlimited scalability. ISS has been working with the leading open source projects and developed a commercial high performance solution that is able to grow forever without performance limitations. In his session at Cloud Expo, Alex Gorbachev, President of Intelligent Systems Services Inc., shared foundation principles of Ceph architecture, as well as the design to deliver this storage to traditional SAN storage co...
Countless business models have spawned from the IaaS industry. Resell Web hosting, blogs, public cloud, and on and on. With the overwhelming amount of tools available to us, it's sometimes easy to overlook that many of them are just new skins of resources we've had for a long time. In his General Session at 16th Cloud Expo, Phil Jackson, Lead Technology Evangelist at SoftLayer, broke down what we've got to work with and discuss the benefits and pitfalls to discover how we can best use them to d...
"We have seen the evolution of WebRTC right from the starting point to what it has become today, that people are using in real applications," noted Dr. Natasha Tamaskar, Vice President and Head of Cloud and Mobile Strategy and Ecosystem at GENBAND, in this SYS-CON.tv interview at WebRTC Summit, held June 9-11, 2015, at the Javits Center in New York City.
Enterprises are turning to the hybrid cloud to drive greater scalability and cost-effectiveness. But enterprises should beware as the definition of “policy” varies wildly. Some say it’s the ability to control the resources apps’ use or where the apps run. Others view policy as governing the permissions and delivering security. Policy is all of that and more. In his session at 16th Cloud Expo, Derek Collison, founder and CEO of Apcera, explained what policy is, he showed how policy should be arch...
The 3rd International WebRTC Summit, to be held Nov. 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA, announces that its Call for Papers is now open. Topics include all aspects of improving IT delivery by eliminating waste through automated business models leveraging cloud technologies. WebRTC Summit is co-located with 15th International Cloud Expo, 6th International Big Data Expo, 3rd International DevOps Summit and 2nd Internet of @ThingsExpo. WebRTC (Web-based Real-Time Com...
It is one thing to build single industrial IoT applications, but what will it take to build the Smart Cities and truly society-changing applications of the future? The technology won’t be the problem, it will be the number of parties that need to work together and be aligned in their motivation to succeed. In his session at @ThingsExpo, Jason Mondanaro, Director, Product Management at Metanga, discussed how you can plan to cooperate, partner, and form lasting all-star teams to change the world...
Internet of Things (IoT) will be a hybrid ecosystem of diverse devices and sensors collaborating with operational and enterprise systems to create the next big application. In their session at @ThingsExpo, Bramh Gupta, founder and CEO of robomq.io, and Fred Yatzeck, principal architect leading product development at robomq.io, discussed how choosing the right middleware and integration strategy from the get-go will enable IoT solution developers to adapt and grow with the industry, while at th...
SYS-CON Events announced today that Harbinger Systems will exhibit at SYS-CON's 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Harbinger Systems is a global company providing software technology services. Since 1990, Harbinger has developed a strong customer base worldwide. Its customers include software product companies ranging from hi-tech start-ups in Silicon Valley to leading product companies in the US a...
The 4th International Internet of @ThingsExpo, co-located with the 17th International Cloud Expo - to be held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA - announces that its Call for Papers is open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than
SYS-CON Events announced today that ProfitBricks, the provider of painless cloud infrastructure, will exhibit at SYS-CON's 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. ProfitBricks is the IaaS provider that offers a painless cloud experience for all IT users, with no learning curve. ProfitBricks boasts flexible cloud servers and networking, an integrated Data Center Designer tool for visual control over the...
"We got started as search consultants. On the services side of the business we have help organizations save time and save money when they hit issues that everyone more or less hits when their data grows," noted Otis Gospodnetić, Founder of Sematext, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
"CenturyLink brings a full suite of services to the table and that enables us to be an IT service provider," explained Jeff Katzen, Director of the Cloud Practice at CenturyLink, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
17th Cloud Expo, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterprises ar...
DevOps is about increasing efficiency, but nothing is more inefficient than building the same application twice. However, this is a routine occurrence with enterprise applications that need both a rich desktop web interface and strong mobile support. With recent technological advances from Isomorphic Software and others, it is now feasible to create a rich desktop and tuned mobile experience with a single codebase, without compromising performance or usability.
One of the hottest areas in cloud right now is DRaaS and related offerings. In his session at 16th Cloud Expo, Dale Levesque, Disaster Recovery Product Manager with Windstream's Cloud and Data Center Marketing team, will discuss the benefits of the cloud model, which far outweigh the traditional approach, and how enterprises need to ensure that their needs are properly being met.